-
1
-
-
34250307235
-
ATP channel-dependent pathway within α cells regulates glucagon release from both rodent and human islets of langerhans
-
DOI 10.1371/journal.pbio.0050143
-
MacDonald PE, De Marinis YZ, Ramracheya R, Salehi A, Ma X, Johnson PR, Cox R, Eliasson L, Rorsman P. A KATP channel-dependent pathway within α-cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 2007;5:1236-1247 (Pubitemid 46919946)
-
(2007)
PLoS Biology
, vol.5
, Issue.6
, pp. 1236-1247
-
-
MacDonald, P.E.1
De Marinis, Y.Z.2
Ramracheya, R.3
Salehi, A.4
Ma, X.5
Johnson, P.R.V.6
Cox, R.7
Eliasson, L.8
Rorsman, P.9
-
2
-
-
33846856711
-
α-cells of the endocrine pancreas: 35 years of research but the enigma remains
-
DOI 10.1210/er.2006-0007
-
Gromada J, Franklin I, Wollheim CB. α-Cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007;28:84-116 (Pubitemid 46220851)
-
(2007)
Endocrine Reviews
, vol.28
, Issue.1
, pp. 84-116
-
-
Gromada, J.1
Franklin, I.2
Wollheim, C.B.3
-
3
-
-
0021711003
-
Insulin within islets is a physiologic glucagon release inhibitor
-
Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 1984;74:2296-2299 (Pubitemid 15197376)
-
(1984)
Journal of Clinical Investigation
, vol.74
, Issue.6
, pp. 2296-2299
-
-
Maruyama, H.1
Hisatomi, A.2
Orci, L.3
-
4
-
-
0023820363
-
The order of islet microsvascular cellular perfusion is B → a → D in the perfused rat pancreas
-
Samols E, Stagner JI, Ewart RBL, Marks V. The order of islet microvascular cellular perfusion is B→A→D in the perfused rat pancreas. J Clin Invest 1988;82:350-353 (Pubitemid 18262537)
-
(1988)
Journal of Clinical Investigation
, vol.82
, Issue.1
, pp. 350-353
-
-
Samols, E.1
Stagner, J.I.2
Ewart, R.B.L.3
Marks, V.4
-
5
-
-
0034801880
-
Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas
-
DOI 10.1097/00006676-200110000-00012
-
Brunicardi FC, Kleinman R, Moldovan S, Nguyen TH, Watt PC, Walsh J, Gingerich R. Immunoneutralization of somatostatin, insulin and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 2001;23:302-308 (Pubitemid 32910980)
-
(2001)
Pancreas
, vol.23
, Issue.3
, pp. 302-308
-
-
Brunicardi, F.C.1
Kleinman, R.2
Moldovan, S.3
Nguyen, T.-H.L.4
Watt, P.C.5
Walsh, J.6
Gingerich, R.7
-
6
-
-
2542532408
-
Regulation of α-cell function by the β-cell during hypoglycemia in Wistar rats: The "switch-off hypothesis."
-
Zhou H, Tran PO, Yang S, Zhang T, LeRoy E, Oseid E, Robertson RP. Regulation of α-cell function by the β-cell during hypoglycemia in Wistar rats: the "switch-off hypothesis." Diabetes 2004;53:1482-1487
-
(2004)
Diabetes
, vol.53
, pp. 1482-1487
-
-
Zhou, H.1
Tran, P.O.2
Yang, S.3
Zhang, T.4
LeRoy, E.5
Oseid, E.6
Robertson, R.P.7
-
7
-
-
63249127193
-
Somatostatin secreted by islet δ-cells fulfills multiple roles as a paracrine regulator of islet function
-
Hauge-Evans AC, King AJ, Carmignac D, Richardson CC, Robinson IC, Low MJ, Christie MR, Persaud SJ, Jones PM. Somatostatin secreted by islet δ-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009;58:403-411
-
(2009)
Diabetes
, vol.58
, pp. 403-411
-
-
Hauge-Evans, A.C.1
King, A.J.2
Carmignac, D.3
Richardson, C.C.4
Robinson, I.C.5
Low, M.J.6
Christie, M.R.7
Persaud, S.J.8
Jones, P.M.9
-
8
-
-
2642593026
-
Autonomic mediation of glucagon secretion during hypoglycemia
-
Taborsky GJ Jr, Ahrén B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia. Diabetes 1998;47:995-1005
-
(1998)
Diabetes
, vol.47
, pp. 995-1005
-
-
Taborsky Jr., G.J.1
Ahrén, B.2
Havel, P.J.3
-
9
-
-
34548207654
-
Brain glucose sensing, counterregulation, and energy homeostasis
-
Bethesda
-
Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda) 2007;22:241-251
-
(2007)
Physiology
, vol.22
, pp. 241-251
-
-
Marty, N.1
Dallaporta, M.2
Thorens, B.3
-
10
-
-
35748957503
-
The physiology of glucagon-like peptide 1
-
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-1439
-
(2007)
Physiol Rev
, vol.87
, pp. 1409-1439
-
-
Holst, J.J.1
-
11
-
-
0025602096
-
Glucagon, catecholamine and pancreatic polypeptide secretion in type 1 diabetic recipients of pancreas allografts
-
Diem P, Redmon JB, Abid M, Moran A, Sutherland DE, Halter JB, Robertson RP. Glucagon, catecholamine and pancreatic polypeptide secretion in type 1 diabetic recipients of pancreas allografts. J Clin Invest 1990;86:2008-2013
-
(1990)
J Clin Invest
, vol.86
, pp. 2008-2013
-
-
Diem, P.1
Redmon, J.B.2
Abid, M.3
Moran, A.4
Sutherland, D.E.5
Halter, J.B.6
Robertson, R.P.7
-
12
-
-
0035512078
-
Pancreatic Response to Mild Non-Insulin-Induced Hypoglycemia Does Not Involve Extrinsic Neural Input
-
Sherck SM, Shiota M, Saccomando J, Cardin S, Allen EJ, Hastings JR, Neal DW, Williams PE, Cherrington AD. Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input. Diabetes 2001;50:2487-2496 (Pubitemid 33642766)
-
(2001)
Diabetes
, vol.50
, Issue.7-12
, pp. 2487-2496
-
-
Sherck, S.M.1
Shiota, M.2
Saccomando, J.3
Cardin, S.4
Allen, E.J.5
Hastings, J.R.6
Neal, D.W.7
Williams, P.E.8
Cherrington, A.D.9
-
13
-
-
0015901935
-
Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic α cell defect
-
Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic α cell defect. Science 1973;182:171-173
-
(1973)
Science
, vol.182
, pp. 171-173
-
-
Gerich, J.E.1
Langlois, M.2
Noacco, C.3
Karam, J.H.4
Forsham, P.H.5
-
14
-
-
33745301045
-
Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: Further evidence for the intraislet insulin hypothesis
-
Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes 2006;55:1051-1056
-
(2006)
Diabetes
, vol.55
, pp. 1051-1056
-
-
Meier, J.J.1
Kjems, L.L.2
Veldhuis, J.D.3
Lefèbvre, P.4
Butler, P.C.5
-
15
-
-
0036227054
-
Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response
-
Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002;51:958-965 (Pubitemid 34438337)
-
(2002)
Diabetes
, vol.51
, Issue.4
, pp. 958-965
-
-
Banarer, S.1
McGregor, V.P.2
Cryer, P.E.3
-
16
-
-
18144396132
-
Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans
-
DOI 10.2337/diacare.28.5.1124
-
Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 2005;28:1124-1131 (Pubitemid 40616623)
-
(2005)
Diabetes Care
, vol.28
, Issue.5
, pp. 1124-1131
-
-
Gosmanov, N.R.1
Szoke, E.2
Israelian, Z.3
Smith, T.4
Cryer, P.E.5
Gerich, J.E.6
Meyer, C.7
-
17
-
-
33644684529
-
Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes
-
DOI 10.2337/diacare.28.11.2691
-
Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE, Meyer C. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes. Diabetes Care 2005;28:2691-2696 (Pubitemid 43951161)
-
(2005)
Diabetes Care
, vol.28
, Issue.11
, pp. 2691-2696
-
-
Israelian, Z.1
Gosmanov, N.R.2
Szoke, E.3
Schorr, M.4
Bokhari, S.5
Cryer, P.E.6
Gerich, J.E.7
Meyer, C.8
-
18
-
-
14644439841
-
Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes
-
Raju B, Cryer PE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes. Diabetes 2005;54:757-764
-
(2005)
Diabetes
, vol.54
, pp. 757-764
-
-
Raju, B.1
Cryer, P.E.2
-
19
-
-
33144467088
-
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
-
DOI 10.1073/pnas.0510790103
-
Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren P-O, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006;103:2334-2339 (Pubitemid 43271670)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.7
, pp. 2334-2339
-
-
Cabrera, O.1
Berman, D.M.2
Kenyon, N.S.3
Ricordi, C.4
Berggren, P.-O.5
Caicedo, A.6
-
21
-
-
34547808932
-
Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes
-
DOI 10.1210/jc.2007-0244
-
Pörksen S, Nielsen LB, Kaas A, Kocova M, Chiarelli F, Orskov C, Holst JJ, Ploug KB, Hougaard P, Hansen L, Mortensen HB, Hvidøre Study Group on Childhood Diabetes. Meal-stimulated glucagon release is associated with blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes. J Clin Endocrinol Metab 2007;92:2910-2916 (Pubitemid 47236349)
-
(2007)
Journal of Clinical Endocrinology and Metabolism
, vol.92
, Issue.8
, pp. 2910-2916
-
-
Porksen, S.1
Nielsen, L.B.2
Kaas, A.3
Kocova, M.4
Chiarelli, F.5
Orskov, C.6
Holst, J.J.7
Ploug, K.B.8
Hougaard, P.9
Hansen, L.10
Mortensen, H.B.11
-
22
-
-
0019946118
-
Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin- dependent diabetic subjects
-
Bohannon NV, Lorenzi M, Grodsky GM, Karam JH. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin- dependent diabetic subjects. J Clin Endorinol Metab 1982;54:459-462
-
(1982)
J Clin Endorinol Metab
, vol.54
, pp. 459-462
-
-
Bohannon, N.V.1
Lorenzi, M.2
Grodsky, G.M.3
Karam, J.H.4
-
23
-
-
0842334505
-
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency
-
Østergård T, Degn KB, Gall M-A, Carr RD, Veldhuis JD, Thomsen MK, Rizza RA, Schmitz O. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency. J Clin Endocrinol Metab 2004;89:297-302
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 297-302
-
-
Østergård, T.1
Degn, K.B.2
Gall, M.-A.3
Carr, R.D.4
Veldhuis, J.D.5
Thomsen, M.K.6
Rizza, R.A.7
Schmitz, O.8
-
24
-
-
57249098943
-
The barrier of hypoglycemia in diabetes
-
Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
-
(2008)
Diabetes
, vol.57
, pp. 3169-3176
-
-
Cryer, P.E.1
-
25
-
-
34249858600
-
Fasting hyperglycemia impairs glucose- But not insulin-mediated suppression of glucagon secretion
-
DOI 10.1210/jc.2006-1515
-
Abdul-Ghani M, DeFronzo RA. Fasting hyperglycemia impairs glucose-but not insulin-mediated suppression of glucagon secretion. J Clin Endocrinol Metab 2007;92:1778-1784 (Pubitemid 46997188)
-
(2007)
Journal of Clinical Endocrinology and Metabolism
, vol.92
, Issue.5
, pp. 1778-1784
-
-
Abdul-Ghani, M.1
Defronzo, R.A.2
|